Are you Dr. Kurtoglu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 32 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Center Dr
Bldg 10 Room 12n226
Bethesda, MD 20892Phone+1 301-496-4916- Is this information wrong?
Summary
- Dr. Metin Kurtoglu, MD is an internist in Bethesda, Maryland. He is currently licensed to practice medicine in District of Columbia and Florida.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2010 - 2013
Istanbul University FomClass of 2002
Certifications & Licensure
DC State Medical License 2013 - 2014
FL State Medical License Active through 2014
Clinical Trials
- Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma Start of enrollment: 2018 Feb 26
Publications & Presentations
PubMed
- 101 citationsDistribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1–expressing myeloma cellsAlejo A. Morales, Metin Kurtoglu, Shannon M. Matulis, Jiangxia Liu, David Siefker
Blood. 2011-08-04 - 43 citationsActivation of the Unfolded Protein Response by 2-Deoxy-d-Glucose Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication and Gene ExpressionHoward J. Leung, Elda M. Duran, Metin Kurtoglu, Samita Andreansky, Theodore J. Lampidis
Antimicrobial Agents and Chemotherapy. 2012-11-01 - 158 citations2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.Haibin Xi, Metin Kurtoglu, Huaping Liu, Medhi Wangpaichitr, Min You
Cancer Chemotherapy and Pharmacology. 2011-04-01
Press Mentions
Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021
A More Targeted CAR-T Cell-Based Therapy for Myasthenia Gravis Moves into Clinical Trial with University of FloridaNovember 7th, 2019
Cartesian Initiates CAR-T Clinical Trial in Myasthenia GravisNovember 5th, 2019
